BioNxt Solutions Inc. Secures European Patent for Innovative Anticancer Drug Delivery System
BioNxt Solutions Inc. has received a formal notice from the European Patent Office to grant a patent for its innovative anticancer drug delivery technology, a key milestone for the company’s lead product BNT23001.
2 minutes to read